Affordable Pump Therapy Plan | Medtronic Diabetes

references

* $49/month estimate is based on average out-of-pocket cost paid over 48 months. monthly payments include a $6/mo. service charge. final cost may be higher or lower than $49/month depending on individual insurance. § refers to automatic mode. The individual results can change. some interaction required.

Reading: How to get an insulin pump without insurance

program terms

• $49/month estimate is based on average out-of-pocket cost paid over 48 months.
• monthly payments include a $6/month service fee.
• final cost may be higher or lower than $49/month depending on individual insurance.
• The patient may choose to pay part or all of the initial cost at any time, without penalty.
• Starter Kit includes one (1) transmitter and a 90-day supply of sensors, infusion sets, and reservoirs associated with your insulin pump.
• Monthly flex payments do not include ongoing supplies, except for the first 90 days. to continue using pump therapy, patients must purchase additional transmitters, sensors, infusion sets, and reservoirs separately.
• No advance payment is required and the first month’s payment will begin 30-60 days after the pump is shipped. individual payment terms may vary.
• minimed™ pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend that you consult your health care provider.
• A valid prescription will be required to purchase. other restrictions may apply.
• The terms of the program are subject to change at any time and without notice.

the minimed™ 770g system is designed for continuous delivery of basal insulin (at user-selectable rates) and bolus insulin delivery (at user-selectable amounts) for the management of type 1 diabetes mellitus in people two years of age and older who require insulin, as well as for continuous monitoring and trending of glucose levels in the fluid under the skin. the minimed™ 770g system includes smartguard™ technology, which can be programmed to automatically adjust basal insulin delivery based on continuous glucose monitoring (cgm) sensor glucose values ​​and can suspend insulin delivery when the sg value falls below or is predicted to fall below predefined threshold values. the medtronic minimed™ 770g system consists of the following devices: minimed™ 770g insulin pump, guardian™ link transmitter (3), guardian™ sensor (3), one-touch inserter, accu blood glucose meter -chek® guide link and accu-chek® guide test strips. the system requires a prescription. The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly to make adjustments to therapy, but rather to provide an indication of when a finger stick may be required. all therapy settings should be based on measurements obtained with a blood glucose meter and not on values ​​provided by the guardian™ sensor (3).

All therapy settings should be based on measurements obtained with the Accu-Chek® Guide Link Blood Glucose Meter and not on values ​​provided by the Guardian™ Sensor (3). Always check the display on your pump to make sure the displayed glucose result matches the glucose results displayed on the Accu-Chek® Guide Link Blood Glucose Meter. do not calibrate your cgm device or calculate a bolus using a blood glucose meter result taken from an alternate site. It is not recommended to calibrate your cgm device when sensor or blood glucose values ​​change rapidly, for example, after a meal or physical exercise.

See also : Unemployment Insurance – NYC Business

Warning: Do not use the smartguard™ automatic mode for people who require less than eight units or more than 250 units of total daily insulin per day. A total daily dose of at least eight units, but not more than 250 units, is required to operate in the automatic smartguard™ mode.

Warning: Do not use the minimed™ 770g system until you have received appropriate training from a healthcare professional. training is essential to ensure the safe use of the minimed™ 770g system.

Pump therapy is not recommended for people whose vision or hearing does not allow them to recognize the signals and alarms of the pump. pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the minimed™ 770g system has not been studied in pregnant women. For complete system details, including product and important safety information such as indications, contraindications, warnings, and precautions associated with the system and its components, see https://www.medtronicdiabetes.com/important-safety-information#minimed -770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library

Indicated for the continuous administration of insulin, at fixed and variable rates, for the control of diabetes mellitus. the minimed™ 630g system is approved for ages 14 and older with guardian™ sensor 3 and the minimed™ 630g system is approved for ages 16 and older with enlite™ sensor. both systems require a prescription. insulin infusion pumps and associated components of insulin infusion systems are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks of insulin pump therapy. pump therapy is not recommended for people who are unwilling or unable to perform a minimum of four blood glucose tests per day. pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. pump therapy is not recommended for people whose vision or hearing does not allow them to recognize the signals and alarms of the pump. insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you should be prepared to replace the forgotten insulin right away. Replace your infusion set every 48 to 72 hours, or more often as instructed by your healthcare professional. insertion of a glucose sensor may cause bleeding or irritation at the insertion site. See a doctor right away if you experience significant pain or suspect the site is infected. The information provided by the CGM systems is intended to supplement, not replace, blood glucose information obtained with a blood glucose meter. A confirmatory fingerstick with a 2.4-meter contour®next link device is required before making adjustments to diabetes management. Always check the display on your pump when using a contour®next link 2.4 meter to make sure the displayed glucose result matches the glucose results displayed on the meter. do not calibrate your cgm device or calculate a bolus using an alternate site (palm) result or a control solution test result. if a control solution test is out of range, be aware that the result may be transmitted to your pump when it is in the “always” send mode. It is not recommended to calibrate your cgm device when sensor or blood glucose values ​​change rapidly, for example, after a meal or physical exercise. the minimed™ 630g system is not intended to be used directly to prevent or treat hypoglycemia, but rather to suspend insulin delivery when the user is unable to respond to the low suspend alarm and take steps to prevent or treat hypoglycemia itself same. therapy to prevent or treat hypoglycemia should be administered in accordance with the recommendations of the user’s health care provider.

warning: the smartguard™ suspend low feature will cause the pump to temporarily suspend insulin delivery for two hours when your sensor glucose reaches a set threshold. under some conditions of use, the pump may be suspended again, resulting in very limited insulin delivery. prolonged withdrawal may increase the risk of severe hyperglycemia, ketosis, and ketoacidosis. Before using the smartguard™ feature, it is important to read the smartguard™ feature information in the user guide and discuss the proper use of the feature with your healthcare provider.

See also : What to Know About Cashing Out Life Insurance While Alive

please refer to the relevant important safety information and user guides for additional important details.

insertion of a glucose sensor may cause bleeding or irritation at the insertion site. See a doctor right away if you experience significant pain or suspect the site is infected. visit important safety information for more details.

contour®next link 2.4 meters is used with the minimed™ 630g system.

940m20191-013 04Apr2019

ascensia, the ascensia diabetes care logo, and the outline are trademarks and/or registered trademarks of ascensia diabetes care.

Source: https://amajon.asia
Category: Other